Tandem Investment Advisors, Inc. / ABT
Tandem Investment Advisors, Inc.’s Abbott Laboratories Position
Does Tandem Investment Advisors, Inc. own Abbott Laboratories (ABT)? Yes — 630.6K shares worth $65M (+3.17% of its 13F portfolio) as of Q1 2026, down from 992.8K shares the prior filed quarter.
Position Value
$65M
Q1 2026
Shares
630.6K
% of Portfolio
+3.17%
Quarters Held
28
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 630.6K | $65M | +3.17% |
| Q4 2025 | 992.8K | $124M | +4.63% |
| Q3 2025 | 992.7K | $132,957 | +4.54% |
| Q2 2025 | 992.8K | $135,026 | +4.73% |
| Q1 2025 | 987.6K | $131,002 | +4.57% |
| Q4 2024 | 992.6K | $112,273 | +4.25% |
| Q3 2024 | 992.4K | $113,145 | +4.29% |
| Q2 2024 | 996.3K | $103,528 | +4.12% |
| Q1 2024 | 964.1K | $109,577 | +4.24% |
| Q4 2023 | 916.5K | $100,884 | +4.03% |
| Q3 2023 | 963.4K | $93M | +3.94% |
| Q2 2023 | 914.2K | $99,664 | +4.38% |
| Q4 2022 | 734.0K | $80,590 | +4.16% |
| Q3 2022 | 742.8K | $72M | +4.09% |
| Q1 2022 | 666.2K | $79M | +4.83% |
| Q4 2021 | 598.8K | $84M | +5.48% |
| Q3 2021 | 569.3K | $67M | +5.51% |
| Q2 2021 | 538.9K | $62M | +5.35% |
| Q1 2021 | 507.6K | $61M | +5.84% |
| Q4 2020 | 439.9K | $48M | +5.17% |
| Q3 2020 | 405.5K | $44M | +5.41% |
| Q2 2020 | 380.8K | $35M | +4.70% |
| Q1 2020 | 456.1K | $36M | +5.34% |
| Q4 2019 | 402.4K | $35M | +5.85% |
| Q3 2019 | 388.7K | $33M | +5.89% |
| Q2 2019 | 359.7K | $30M | +5.73% |
| Q1 2019 | 329.2K | $26M | +5.80% |
| Q4 2018 | 301.4K | $22M | +5.66% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tandem Investment Advisors, Inc.’s full portfolio or all institutional holders of ABT.